UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050041
Receipt number R000056421
Scientific Title Prospective Randomized Trial of the Efficacy for Intra-Articular Versus Extra-Articular steroid Injections in Knee Osteoarthritis
Date of disclosure of the study information 2023/01/17
Last modified on 2023/01/25 09:53:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Randomized Trial of the Efficacy for Intra-Articular Versus Extra-Articular steroid Injections in Knee Osteoarthritis

Acronym

SI study for knee OA

Scientific Title

Prospective Randomized Trial of the Efficacy for Intra-Articular Versus Extra-Articular steroid Injections in Knee Osteoarthritis

Scientific Title:Acronym

SI study for knee OA

Region

Japan


Condition

Condition

Knee osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy for Intra-Articular Versus Extra-Articular steroid Injections in Knee Osteoarthritis and reveal the localization of the pain of knee osteoarthritis

Basic objectives2

Others

Basic objectives -Others

To investigate the association between MRI or plain radiography and the effect by the injection of steroid and do the sub group comparison

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The score of KOOS and NRS after the injection of steroid during 12 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intraarticular steroid injection

Interventions/Control_2

Extraarticular steroid injection

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Age over 40 years old
2. Person who has been diagnosed as knee osteoarthritis regarding ACR criteria.
3. Person who has been informed and became consent with the study

Key exclusion criteria

1 Rheumatoid arthritis, multiple arthritis, and other autoimmune disease
2 History of total knee arthroplasty, high tibial osteotomy, and other knee surgery
3 History of intra-articular steroid injection in 6 months
4 In use of opioid analgesics
5 A plan for change of residence or long absence
6 Having difficulty talking Japanese
7 Having difficulty answering to questionnaires for cognitive decline
8 Inappropriate for injection
9 History of hypersensitivity for steroids
10 Person whom principal Investigator or co-Investigator judge to be inappropriate

Target sample size

58


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Watanabe

Organization

Nippon Medical School

Division name

Department of Orthopaedic Surgery

Zip code

113-8603

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan

TEL

03-3822-2131

Email

watanabehiroshi@nms.ac.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Watanabe

Organization

Nippon Medical School Musashi-Kosugi Hospital

Division name

Department of Orthopaedic Surgery

Zip code

211-8533

Address

1-383 Kosugi-machi, Nakahara-ku, Kawasaki, Kanagawa

TEL

044-733-5181

Homepage URL


Email

watanabehiroshi@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School

Institute

Department

Personal name

HIROSHI WATANABE


Funding Source

Organization

Nippon Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Toho Kamagaya Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chuorinri group

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

Tel

03-3822-2131

Email

chuorinri.group@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 12 Month 20 Day

Date of IRB

2022 Year 12 Month 22 Day

Anticipated trial start date

2023 Year 01 Month 24 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 14 Day

Last modified on

2023 Year 01 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056421


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name